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A B S T R A C T
Dengue virus is the most important mosquito-borne viral disease in the world. Co-circulation 
of the four types of dengue viruses and expansion of dengue epidemic gave rise to infection 
enhancement and a big expansion of clinical aspects of the disease. Herein we report a case of 
a 25-year-old white woman with dengue fever and numerous associated autoimmune features. 
Our patient had proteinuria, an extensive right pleural effusion, a thin pericardial effusion 
and ascites. She had a low C3 level and positive antinuclear antibody; cryoglobulins were also 
positive. The numerous autoimmune features of this patient were a diagnostic challenge, since 
she was a young woman and could be easily mistaken for a rheumatologic patient in a newly 
open disease. Dengue infection probably was a triggering event causing an abnormal immune 
response. Therefore, dengue should be suspected in patients with hematological disorders and 
autoimmune features in endemic regions or those who have travelled to those regions.
© 2012 Elsevier Editora Ltda. All rights reserved.
Introduction 
The dengue virus is a RNA virus belonging to the Flaviviridae 
family1 and is the most important mosquito-borne viral 
disease in the world. There are four dengue viruses 
transmitted mainly in tropical countries and virulence 
seems to be quite variable among them.2 Classically, 
infection may be clinically asymptomatic or results in 
undifferentiated fever,  dengue fever (DF) ,  dengue 
hemorrhagic fever (DHF) or dengue shock syndrome (DSS). 
However, the co-circulation of the four types of dengue 
viruses and expansion of dengue epidemic gave rise 
to infection enhancement and, consequently, not only 
significant number of severe forms – including dengue 
hemorrhagic fever (DHF) and dengue shock syndrome 
(DSS) – but also a an increasing number of “unusual 
complications”.
T h e  m a j o r  p a t h o p h y s i o l o g i c a l  h a l l m a r k  t h a t 
distinguishes DHF/DSS from DF is plasma leakage as a 
result of increased vascular permeability. That feature is 
observed instead of hemorrhagic events with secondary 
hypoalbuminemia or hypoproteinemia, accompanied 
by thrombocytopenia, altered haemostasis, and, usually, 
evidence of liver damage (indicated by increased aspartate 
aminotransferase and alanine aminotransferase). In DHF, 
but not in DF, there is an enhanced immune response in 
a host, most of them with a secondary infection, resulting 
in the formation of circulating immune complexes, 
complement activation, increased histamine release and 
massive release of cytokines into the blood,3 which can give 
origin to many unusual clinical features.
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Case presentation
A 25-year-old white woman was admitted to our hospital in 
May 2007 with a two-week history of fever, myalgia, headache 
and a few petechial lesions on the lower extremities. She took 
acetaminophen at standard doses as instructed in another 
service. On the seventh day of symptoms she developed 
disabsortive diarrhea, nausea, painful enlargement of the 
abdomen, edema in the legs, dyspnea and orthopnea. She had 
given birth five months before. She reported the occurrence 
of many cases of dengue infection in the area where she lived 
and State of São Paulo Department of Health data showed a 
dengue outbreak caused by dengue 3 serotype virus (DENV 3) 
in many regions, including that specific area. 
At admission, fourteen days after the beginning of 
her first symptoms, she presented high temperature, 
tachycardia (120 bpm), tachypnea and blood pressure 
of 100 x 70 mmHg. Clinical examination revealed right 
prominent pleural effusion, ascites, epigastric discomfort, 
tender hepatomegaly and splenomegaly, soft edema 
and a few petechiae on the legs. There were no signs of 
active bleeding and the tourniquet test was negative. 
Her history of previous infectious diseases and recent 
trips was also negative. Laboratory results at admission 
showed leucopenia, thrombocytopenia, elevated aspartate 
aminotransferase, alanine aminotransferase levels and 
γ-glutamyltransferase levels, hypoalbuminemia, proteinuria, 
and elevated C-reative protein (7.62 mg/dL, [normal 
range < 0.5mg/dL]) and lactate dehydrogenase (Table 1). 
Extensive right pleural effusion was observed by chest 
X-ray (Fig. 1) and computed tomography also showed a thin 
pericardial effusion, which was subsequently confirmed by 
Fig. 1 - Chest X-ray at admission (A) and 2 weeks after hospital discharge (B).
Variable / (unit) / [normal range] Admission Day 4 Discharge Follow-up
Hematocrit (%)  [37-47]  37.6 28.8 30 33.2
White cells (per mm3) [4,000-10,000] 3,750 3,340 5,130 7,670
Neutrophils (per mm3) [2,000-8,000] 2,150 1,560 2,110 4,540
Lymphocytes (per mm3 ) [1,000-4,000] 840 1,000 2,240 2,320
Platelet count (per mm3) [150-400,103] 95,000 94,000 325,000 299,000
Alanine aminotransferase (U/L) [≤ 34] 353 170 49 21
Aspartate aminotransferase (U/L) [≤ 27] 370 209 53 29
Alkaline phosphatase (U/L) [≤  104] 206 162 - 117
γ-glutamyltransferase (U/L) [≤ 42] 177 134 - 93
Prothrombin time (sec) 20.2 36.4 13.0 12.6
Activated partial thromboplastin time (sec) 39.5 50.7 28.6 30.2
Albumin (g/dL) [3.4-4.8] 2.6 1.8 - 3.9
Cryoglobulin Positive - - Negative
C3 (g/L) [0.9-1.8] - 0.39 - 1.89
C4 (g/L) [0.1-0.4] - 0.33 - 0.46
ANA titers - 1/320 - Negative
ANA, antinuclear antibodies.
Table 1 - Evolution of laboratory results
(A) (B)
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echocardiography. Abdominal ultrasound and computed 
tomography revealed hepatomegaly, splenomegaly, and ascites 
but no lymphadenopathy was seen. Analyses of ascites and 
pleural effusion performed two days following admission 
revealed a lymphomonocytic exsudate with elevated levels of 
adenosine deaminase (ADA) of 39.8 and 49.6 U/L, respectively 
(normal range ≤ 40 U/L) . Microbiological studies (for bacterial, 
mycobacterial, and fungal infectios) were negative. Cytological 
analyses of the pleural effusion showed cells suggestive of “LE 
cells”. Bacterial and parasitological examination of feces showed 
no pathological findings. A 0.55 g/day proteinuria was quantified.
At admission, low C3 (0.39 g/L) and normal C4 levels 
were observed. A positive detection of antinuclear antibody 
showed a “mitotic spindle” fluoroscopic pattern. Cryoglobulins 
were also positive while antibodies to native DNA were negative. 
Serologic tests for Epstein-Barr virus, toxoplasmosis, syphilis, 
cytomegalovirus, HIV, and hepatitis B and C were negative. 
Dengue serological tests were performed and included dengue 
IgM capture enzyme-linked immunosorbent assay (Panbio – 
Queensland, Australia) positive and dengue virus IgM- and 
IgG specific tests (Dengue DuoCassette, PanBio), both IgM 
and IgG positives. These serological findings were strongly 
suggestive of recent dengue virus infection. Due to the advanced 
time of acute infection, a detection of dengue non-structural 
protein 1 (NS1) was not indicated.
Treatment was symptomatic with administration of 
crystalloids, fresh frozen plasma and vitamin K. Because a 
secondary bacterial infection could not be ruled out she also 
received antibiotics. During the first week of hospitalization 
patient had fever, impaired respiration and one episode of 
vaginal bleeding. At that time, she developed prolonged 
thrombin time, a drop in hemoglobin levels, and fibrinogen 
consumption (85.5 mg%; [normal range 220-495 mg%]) (Table 1).
Her clinical condition and laboratory tests improved during 
the second week and on discharge her clinical symptoms 
had almost disappeared. A relative lymphocytosis and 
reticulocytosis were observed during the recovering phase. 
At the first follow-up visit, she presented complete recovery and 
laboratory tests had normalized, including negative 
antinuclear antibodies.
Discussion
We have reported the case of a patient presenting with 
autoimmune features as an unusual complication of dengue 
virus infection. The severity of dengue infection is usually 
correlated with the size of the dengue-infected cell mass as 
shown many times by high titers of circulating virus in early 
illness blood samples or by persisting high concentrations 
in blood of dengue viral RNA and dengue non-structural 
protein 1 (NS1).4 This protein also parallels cellular dengue 
infection. High levels of markers of immune activation and 
severity of dengue infection have led to the hypothesis 
of an autoimmune response, mainly as a result of cross-
reactivity between anti-NS1 to host proteins, endothelial 
cells and platelets,5,6 mediating complement activation3 and 
triggering plasma leakage. Molecular mimicry could be 
involved in the pathogenesis of this autoimmune activation. 
Dengue infection may also lead to a wide range of 
hematological disorders, including thrombocytopenia, 
bone marrow suppression, platelet dysfunction, acti- 
vation of fibrinolysis and disseminated intravascular 
coagulation (DIC).7,8 Our patient met the WHO criteria 
for DHF and showed abnormalities compatible with 
bone marrow suppression, and DIC, although major 
hemorrhagic manifestations were not observed. The 
probable immunological mechanism was suggested by 
the wide spectrum of laboratorial abnormalities: a low level 
of C3 complement, positive antinuclear antibodies, positive 
cryoglobulins and elevated ADA in serositis. Prolonged 
symptoms from dengue infections, such as we observed, are 
not common and could lead to diagnostic difficulties. Plasma 
leakage is the hallmark of DHF and occurs late during the 
acute infection at or near defervesence and is coincident 
with the clearance of virus,9 It could be demonstrated by 
hypoalbuminemia and cavitary effusions. We were able to 
detect specific antibody production against dengue virus 
during the phase of DHF, probably also coincident with 
lowering of virus titers.
The numerous autoimmune features of this patient were 
a diagnostic challenge, since she was a young woman and 
could be easily confounded with a rheumatologic patient 
in a newly open disease. Dengue infections can be a triggering 
event causing abnormal immune response leading to atypical 
symptoms or autoimmune diseases, such as systemic lupus 
erythematosus.10 Therefore, this infection should be included 
in differential diagnosis of patients with hematological 
disorders and autoimmune features in endemic regions or 
with those who have traveled to them.
Conclusion
Our patient demonstrated anemia, thrombocytopenia, 
leucopenia and abnormal coagulation studies (prolonged 
activated partial thromboplastin time and thrombin 
time and low fibrinogen levels) in combination with features 
of autoimmune disorders such as elevation of C-reactive 
protein, low complement levels, positive cryoglobulins, 
and positive antinuclear antibodies. The description of 
the case that at first resembled a systemic autoimmune 
disease, including systemic lupus erythematosus and 
cryoglobulinemia, was subsequently confirmed as part of 
dengue hemorrhagic fever manifestations. Due to the high 
frequency of these features in the clinical practice and 
the increasing incidence of dengue fever, we think that 
c l i n i c i a n s  s h o u l d  i n c l u d e  d e n g u e  i n f e c t i o n  i n 
the differential diagnosis of patients with hematological 
disorders and autoimmune features. Besides, to our 
knowledge, this is the first report of such autoimmune 
features in dengue infection.
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